November 27, 2018 / 6:22 AM / 13 days ago

BRIEF-Sandoz Receives 8th European Commission Approval For Biosimilar Ziextenzo

Nov 27 (Reuters) - Novartis AG:

* SANDOZ RECEIVES EIGHTH EUROPEAN COMMISSION APPROVAL FOR A BIOSIMILAR WITH ZIEXTENZO® (PEGFILGRASTIM) Source text for Eikon: Further company coverage: (Reporting by Berlin Speed Desk)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below